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Relationship between hyporesponsiveness to clopidogrel and in stent restenosis
in patients undergoing percutaneous coronary intervention
Fu Zhenhong, Wei Dong, Hao Xue, Jun Guo, Chen Yundai
Chinese People’s Liberation Army General Hospital
Objectives: The relationship between hyporesponsiveness to clopidogrel and in stent
restenosis (ISR) was analyzed, and the cut-off value of hyporesponsiveness to clo-
pidogrel for ISR was evaluated.
Methods: 861 consecutive patients enrolled and patients’ inhibition rates in
arachidonic acid (AA) and adenosine 50-diphosphate (ADP) pathways
were measured by thrombelastography (TEG) system. Patients were
divided into ISR and non-ISR groups according to the results of coronary
angiography. Correlation between hyporesponsiveness to clopidogrel and ISR
was analyzed.
Results: 249 patients were in ISR group and 612 patients were in non-ISR
group. The average interval from the ﬁrst PCI to the second CAG was 13
(IQR9-16) months. The frequency of clopidogrel hyporesponsiveness in
ISR group was signiﬁcantly higher than that in non-ISR group (P<0.01).
Inhibition rates in AA and ADP pathways in ISR group were lower than
those in non-ISR group (P<0.01). The inhibition rate in ADP pathway was
inversely correlated with (r¼-0.225, P¼0.001) the severity of ISR. After being
adjusted for traditional covariates, the inhibition rate in ADP pathway (b¼-
0.191, R2¼0.011, P¼0.013) remained independently associated with the severity
of ISR, clopidogrel hyporesponsiveness was an independent risk factor of ISR
(HR 6.62, 95% CI 2.84-15.49, P ¼0.001). ROC curve analysis showed that the
predictive cut-off value of the inhibition rate in ADP pathway for ISR was
10.1%.
Conclusions: The inhibition rate in ADP pathway is inversely related to the ISR
severity. Clopidogrel hyporesponsiveness is an independent risk factor for ISR and
can predict the risk of ISR.GW25-e4571
The effects of a loading-dose of atorvastatin before primary percutaneous
coronary intervention on coronary ﬂow and serum sCD40L in patients with
ST-segment elevation myocardial infarction
Wu Mingwei, Yong Yang, Huiliang Liu
The General Hospital of Chinese Armed Police Forces
Objectives: The purpose of this paper was to evaluate the effect of a loading-dose
treatment of atorvastatin before primary percutaneous coronary intervention on cor-
onary ﬂow and serum sCD40L in patients with ST-segment elevation myocardial
infarction.
Methods: From May, 2012 to October, 2013 STEMI patients who prepared to
perform primary PCI were screened. They were randomly divided into three
groups: group A (received atorvastatin 80 mg loading dose before PCI then fol-
lowed by 40mg daily for one month and a maintenance dose of 20mg daily
thereafter) ;group B (received atorvastatin 40mg daily after PCI for one month and
a maintenance dose of 20mg daily thereafter) ;group C (received atorvastatin 20mg
daily after PCI). The serum levels of sCD40L were recorded at 24h, 7d, 30d after
PCI. The immediate post operation TIMI ﬂow grade and corrected TIMI Frame
count were recorded. Drug safety included elevated liver enzymes (more than 3
times the uper limit of normal value), myalgia, rhabdomyolysis, gastrointestinal
reaction and rash.
Results: A total of 198 STEMI patients were screened during our study. Ulti-
mately 136 patients were randomly assigned to group A (N¼48), group B,
(N¼43), and group C (N¼45). (1) The baseline data, angiography results, PCI
procedure and medication among the 3 groups were not statistically different and
were comparable.
(2) Comparison of serum sCD40L level among the three groups: ① No sig-
niﬁcant difference was found among the 3 groups on the serum sCD40L levels
(P>0.05). ② 24 hours after PCI, the level of serum sCD40L (xs, ng/ml) three
groups were 16.184.52, 18.255.02, 18.664.17 respectively, P¼0.022.
Serum sCD40L level of A group was lower than those in B and C group
(P<0.05).There was no statistical signiﬁcance difference between B and C
group (P>0.05). ③ 7 days after PCI, the level of serum sCD40L (xs, ng/ml)
three group were 3.921.44, 4.631.68, 4.681.51 respectively, P¼0.035.
Serum sCD40L level of A group was lower than those in B and C group
(P<0.05). There was no statistical signiﬁcance difference between B and C
group (P>0.05). ④ 30 days after PCI, no statistically signiﬁcant difference
among the three groups on the serum sCD40L levels were found (P>0.05). (3)
Immediate coronary ﬂow after primary comparison among the three groups: ①
There was no statistical difference among the three groups on the ratio of
reached TIMI ﬂow grade 3 (P>0.05). ② The immediate postoperative cTFC
(Corrected TIMI frame count) in three groups (xs) were 25.4412.07,
30.9812.09, 33.49 14.56, respectively. The differences among three groups
reached statistical signiﬁcance. The differences between group A and group B,
group A and group C both reached statistical signiﬁcance (P<0.05).No sig-
niﬁcant difference between group B and group C was found (P>0.05). TheJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/CcTFC of A group was lower than that of B and C group. (4) Drug safety
monitoring: there were no signiﬁcant difference among three groups on the
occurrence of drug adverse reactions, the changes of liver enzyme and creatine
kinasewas during the study.
Conclusions: For STEMI patients who undergoing primary PCI, a loading-dose of
atorvastatin before PCI could reduce serum sCD40L level, improve coronary ﬂow and
did not increase the incidences of adverse events.GW25-e4584
The safety and efﬁcacy of dual-axis rotational coronary angiography in the
diagnosis of coronary artery disease
Yang Shengli, Hui-Liang Liu
Department of Cardiology, General Hospital of Chinese People’s Armed Police
Forces, Beijing, China
Objectives: This study evaluates the efﬁcacy and safety of Dual-axis rotational cor-
onary angiography (DARCA) (X-per Swing) in the diagnosis of coronary artery
disease.
Methods: From March to July in 2010, consecutive 79 patients undergoing diagnostic
coronary angiography were randomized to either standard angiography group (n¼39)
or X-per Swing angiography group (n¼40). We measured the quantity of contrast
utilized and radiation exposure.
Results: Both groups were successfully completed angiography. There was a 44%
reduction in contrast utilization in the X-per Swing group compared to the standard
group (29.285.06 ml vs. 52.0212.05 ml, P<0.001). Additionally, there was a 50%
reduction in radiation exposure in the X-per Swing group compared to the standard
group (69003443.03 mGycm2 vs. 168578584.68 mGycm2, P<0.001). Neither
arrhythmia nor chest pain differed in both groups. X-per Swing can provides a sigi-
niﬁcant reduction of contrast and radiation exposure while maintaining comparable
diagnostic accuracy and safety. With an auto-inject system (ACIST CMS2000) that
can autoinject contrast by interlinkage, operator can stay far away from X-ray tube,
which enable the X-ray exposure to be extremely reduced.
Conclusions: X-per Swing represents a new angiographic technique which is
equivalent in terms of image quality and is associated with less contrast use, radiation
exposure and procedural time than SA.GW25-e5158
Serum Cystatin C Level Not Associated with Coronary Artery Plaque
Vulnerability Analyzed by Optical Coherence Tomography
Jin Qinhua, Chen Yun Dai
Chinese PLA Gneral Hospital
Objectives: Cystatin C, which is an endogenous marker for renal function, is reported
to be a novel marker for coronary atherosclerosis. Some studies showed that lower
cystatin C levels may be associated with increased severity of CAD in clinically stable
patients, whereas higher levels may indicate the presence of any vulnerable plaque. To
evaluate the relationship of Serum Cystatin C level and the coronary artery plaque
vulnerability assessed by OCT in patients with coronary artery disease.
Methods: Eighty-two patients with chest pain underwent OCT assessment after
coronary angiogram, all the lesions with diameter stenosis 30% and <100% were
analyzed. The serum Cystatin C levels were measured, and the variables of plaque
vulnerability, rupture, ﬁbrotic cap thickness, micro channel in plaque were analyzed
by OCT.
Results: One hundred and thirty seven lesions were analyzed, the Cystatin C levels
didn’t exist signiﬁcant difference between the patients with vulnerable plaques and
stable plaques (P¼0.918), no difference between the ruptured plaques or no ruptured
plaques (P¼ 0.990), between plaques with micro channel or not (P¼ 0.570); There
were no relationship between the Cystatin C level and ﬁbrous cap thickness
(r¼-0.233).
Conclusions: In our study, we haven’t found the relationship of Cystatin C level and
plaque vulnerability assessed by OCT.GW25-e0291
Staged PCI combined with optimized medical therapy for mutivessel disease
in acute myocardial infarction
Wang Qingsheng, Wang Qingsheng
The First Hospital of Qinhuangdao
Objectives: In acute myocardial infarction (AMI) and multivessel disease, it was
unknown whether short-term percutaneous coronary intervention (PCI) for non-
infarction related artery (IRA) was better than ischemia related PCI accompanied with
optimized medical therapy.
Methods: This was a retrospective study. From 2009 to 2011, 288 patients with AMI
and mutivessel disease were enrolled who were undergoing primary PCI and assignedardiovascular Disease Clinical Research C143
